Accuray Inc (ARAY)
1.78
+0.21
(+13.38%)
USD |
NASDAQ |
May 31, 16:00
1.79
+0.01
(+0.56%)
After-Hours: 20:00
Accuray Accounts Payable (Quarterly): 44.43M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 44.43M |
December 31, 2023 | 39.18M |
September 30, 2023 | 34.88M |
June 30, 2023 | 33.74M |
March 31, 2023 | 28.65M |
December 31, 2022 | 33.86M |
September 30, 2022 | 32.94M |
June 30, 2022 | 31.34M |
March 31, 2022 | 32.36M |
December 31, 2021 | 29.26M |
September 30, 2021 | 22.57M |
June 30, 2021 | 19.47M |
March 31, 2021 | 17.87M |
December 31, 2020 | 10.88M |
September 30, 2020 | 17.84M |
June 30, 2020 | 23.13M |
March 31, 2020 | 26.53M |
December 31, 2019 | 22.06M |
September 30, 2019 | 23.62M |
June 30, 2019 | 29.56M |
March 31, 2019 | 25.39M |
December 31, 2018 | 31.40M |
September 30, 2018 | 25.92M |
June 30, 2018 | 19.69M |
March 31, 2018 | 23.18M |
Date | Value |
---|---|
December 31, 2017 | 25.92M |
September 30, 2017 | 22.20M |
June 30, 2017 | 17.49M |
March 31, 2017 | 23.63M |
December 31, 2016 | 25.15M |
September 30, 2016 | 17.05M |
June 30, 2016 | 15.23M |
March 31, 2016 | 21.74M |
December 31, 2015 | 19.56M |
September 30, 2015 | 13.65M |
June 30, 2015 | 13.10M |
March 31, 2015 | 13.66M |
December 31, 2014 | 15.98M |
September 30, 2014 | 14.70M |
June 30, 2014 | 15.64M |
March 31, 2014 | 18.14M |
December 31, 2013 | 15.11M |
September 30, 2013 | 18.15M |
June 30, 2013 | 15.92M |
March 31, 2013 | 14.98M |
December 31, 2012 | 20.67M |
September 30, 2012 | 28.02M |
June 30, 2012 | 18.21M |
March 31, 2012 | 23.47M |
December 31, 2011 | 22.02M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
10.88M
Minimum
Dec 2020
44.43M
Maximum
Mar 2024
27.71M
Average
28.95M
Median
Accounts Payable (Quarterly) Benchmarks
Boston Scientific Corp | 921.00M |
ResMed Inc | 177.44M |
Glaukos Corp | 12.75M |
Perspective Therapeutics Inc | 6.027M |
Xtant Medical Holdings Inc | 7.378M |